Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
457.2 USD | +1.41% | +2.17% | +11.79% |
05-22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
05-21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.79% | 116B | |
+12.20% | 106B | |
-9.21% | 23.89B | |
-2.33% | 21.58B | |
-10.90% | 18.96B | |
-41.25% | 16.96B | |
-14.35% | 16.33B | |
+7.53% | 14.14B | |
+31.58% | 12.02B | |
-2.05% | 7.58B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $323 From $261, Maintains Overweight Rating